Search - tctmd.com

Displaying 121 - 140 of 8957

Sort: Relevancy | Date

Presentation TCT 2025

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

Presenter: Gregg W. Stone

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Leverage Artificial Intelligence in Clinical Trials: Opportunities and Challenges

Presenter: Alexandra Popma

October 27, 2025

Presentation TCT 2025

The Challenges of Recurrent Event Models and Multiple Endpoints

Presenter: Daniele Giacoppo

October 27, 2025

Presentation TCT 2025

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Presenter: Devi G. Nair

October 27, 2025

Presentation TCT 2025

Estimands: Clarifying What We’re Measuring in Clinical Trials

Presenter: Roseann M. White

October 27, 2025

Presentation TCT 2025

Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval

Presenter: Sreekanth Vemulapalli

October 27, 2025

Presentation TCT 2025

Current Trials to Extend LAAC Clinical Indications

Presenter: Shephal K. Doshi

October 27, 2025

Presentation TCT 2025

Joint Modelling for Death and Quality of Life: Worthy as a Primary Endpoint

Presenter: John A. Spertus

October 27, 2025

Presentation TCT 2025

Placebo-Controlled Interventional Trials: A Sham No More

Presenter: Rasha Al-Lamee

October 27, 2025

Presentation TCT 2025

TCT 919: Representation of Resuscitated Out of Hospital Cardiac Arrest Patients in Landmark Cardiogenic Shock Clinical Trials - a Simulated Cohort Study

Presenter: Hugh Lurcott

October 27, 2025

Presentation TCT 2025

Spoiler Alert: Crossovers (Treatment Switches) can Negate the Trial Efficacy: Insights from The Ischemia Trial

Presenter: John Gregson

October 27, 2025

Presentation TCT 2025

The Core of Clinical Event Adjudication: Where is CEC Now and Where Do They Go Next?

Presenter: Marc P. Bonaca

October 27, 2025

Presentation TCT 2025

Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial

Presenter: Evald H. Christiansen

October 27, 2025

Presentation TCT 2025

Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders?

Presenter: Rasha Al-Lamee

October 27, 2025

Presentation TCT 2025

Drug-Coated Balloon Angioplasty with Rescue Stenting Versus Intended Stenting for the Treatment of DeNovo Coronary Artery Lesions: 3-Year Clinical Outcomes of the REC-CAGEFREE I Trial

Presenter: Chao Gao

October 27, 2025

Advertisement

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Leverage Artificial Intelligence in Clinical Trials: Opportunities and Challenges

The Challenges of Recurrent Event Models and Multiple Endpoints

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Estimands: Clarifying What We’re Measuring in Clinical Trials

Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval

Current Trials to Extend LAAC Clinical Indications

Joint Modelling for Death and Quality of Life: Worthy as a Primary Endpoint

Placebo-Controlled Interventional Trials: A Sham No More

TCT 919: Representation of Resuscitated Out of Hospital Cardiac Arrest Patients in Landmark Cardiogenic Shock Clinical Trials - a Simulated Cohort Study

Spoiler Alert: Crossovers (Treatment Switches) can Negate the Trial Efficacy: Insights from The Ischemia Trial

The Core of Clinical Event Adjudication: Where is CEC Now and Where Do They Go Next?

Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial

Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders?

Drug-Coated Balloon Angioplasty with Rescue Stenting Versus Intended Stenting for the Treatment of DeNovo Coronary Artery Lesions: 3-Year Clinical Outcomes of the REC-CAGEFREE I Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content